Moneycontrol
HomeNewsIndiaCoronavirus pandemic: FM Sitharaman announces Rs 1.7 lk cr relief under PM Garib Kalyan Scheme

Coronavirus pandemic: FM Sitharaman announces Rs 1.7 lk cr relief under PM Garib Kalyan Scheme

Under the Rs 1.70 lakh crore scheme, cash transfers will be made to poor and migrant workers.

March 26, 2020 / 22:43 IST
Story continues below Advertisement

Finance minister Nirmala Sitharaman, on March 26, announced the Pradhan Mantri Garib Kalyan Scheme to help the poor during the coronavirus pandemic.

Under the Rs 1.70 lakh crore scheme, cash transfers will be made to poor and migrant workers.

Story continues below Advertisement

Amid the COVID-19 outbreak, migrant workers in major cities have been struggling to obtain essential supplies since the 21-day lockdown began. Several of them are also at risk of losing their income and jobs.

Track this blog for latest updates on coronavirus outbreak

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show